BACKGROUND: Higher cumulative burden of depression among people with HIV (PWH) is associated with poorer health outcomes; however, longitudinal relationships with neurocognition are unclear. This study examined hypotheses that among PWH, (1) higher cumulative burden of depression would relate to steeper declines in neurocognition, and (2) visit-to-visit depression severity would relate to fluctuations in neurocognition within persons. SETTING: Data were collected at a university-based research center from 2002 to 2016. METHODS: Participants included 448 PWH followed longitudinally. All participants had >1 visit (M = 4.97; SD = 3.53) capturing depression severity (Beck Depression Inventory-II) and neurocognition (comprehensive test battery). Cumulative burden of depression was calculated using an established method that derives weighted depression severity scores by time between visits and total time on study. Participants were categorized into low (67%), medium (15%), and high (18%) depression burden. Multilevel modeling examined between- and within-person associations between cumulative depression burden and neurocognition over time. RESULTS: The high depression burden group demonstrated steeper global neurocognitive decline compared with the low depression burden group (b = -0.100, P = 0.001); this was driven by declines in executive functioning, delayed recall, and verbal fluency. Within-person results showed that compared with visits when participants reported minimal depressive symptoms, their neurocognition was worse when they reported mild (b = -0.12, P = 0.04) or moderate-to-severe (b = -0.15, P = 0.03) symptoms; this was driven by worsened motor skills and processing speed. CONCLUSIONS: High cumulative burden of depression is associated with worsening neurocognition among PWH, which may relate to poor HIV-related treatment outcomes. Intensive interventions among severely depressed PWH may benefit physical, mental, and cognitive health.
BACKGROUND: Higher cumulative burden of depression among people with HIV (PWH) is associated with poorer health outcomes; however, longitudinal relationships with neurocognition are unclear. This study examined hypotheses that among PWH, (1) higher cumulative burden of depression would relate to steeper declines in neurocognition, and (2) visit-to-visit depression severity would relate to fluctuations in neurocognition within persons. SETTING: Data were collected at a university-based research center from 2002 to 2016. METHODS: Participants included 448 PWH followed longitudinally. All participants had >1 visit (M = 4.97; SD = 3.53) capturing depression severity (Beck Depression Inventory-II) and neurocognition (comprehensive test battery). Cumulative burden of depression was calculated using an established method that derives weighted depression severity scores by time between visits and total time on study. Participants were categorized into low (67%), medium (15%), and high (18%) depression burden. Multilevel modeling examined between- and within-person associations between cumulative depression burden and neurocognition over time. RESULTS: The high depression burden group demonstrated steeper global neurocognitive decline compared with the low depression burden group (b = -0.100, P = 0.001); this was driven by declines in executive functioning, delayed recall, and verbal fluency. Within-person results showed that compared with visits when participants reported minimal depressive symptoms, their neurocognition was worse when they reported mild (b = -0.12, P = 0.04) or moderate-to-severe (b = -0.15, P = 0.03) symptoms; this was driven by worsened motor skills and processing speed. CONCLUSIONS: High cumulative burden of depression is associated with worsening neurocognition among PWH, which may relate to poor HIV-related treatment outcomes. Intensive interventions among severely depressed PWH may benefit physical, mental, and cognitive health.
Authors: Catherine L Carey; Steven Paul Woods; Raul Gonzalez; Emily Conover; Thomas D Marcotte; Igor Grant; Robert K Heaton Journal: J Clin Exp Neuropsychol Date: 2004-05 Impact factor: 2.475
Authors: Ned Sacktor; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; M Kate Grabowski; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Ronald H Gray; Maria J Wawer Journal: J Acquir Immune Defic Syndr Date: 2019-06-01 Impact factor: 3.731
Authors: Jacob D Jones; Taylor Kuhn; Andrew Levine; Ned Sacktor; Cynthia A Munro; Linda A Teplin; Gypsyamber D'Souza; Eileen M Martin; James T Becker; Eric N Miller; Charles H Hinkin Journal: Neuropsychology Date: 2019-03 Impact factor: 3.424
Authors: Robert K Heaton; Donald R Franklin; Reena Deutsch; Scott Letendre; Ronald J Ellis; Kaitlin Casaletto; Maria J Marquine; Steven P Woods; Florin Vaida; J Hampton Atkinson; Thomas D Marcotte; J Allen McCutchan; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Ned Sacktor; Susan Morgello; David M Simpson; Ian Abramson; Anthony C Gamst; Christine Fennema-Notestine; David M Smith; Igor Grant Journal: Clin Infect Dis Date: 2014-10-31 Impact factor: 20.999
Authors: Anna J Dreyer; Sam Nightingale; Lena S Andersen; Jasper S Lee; Hetta Gouse; Steven A Safren; Conall O'Cleirigh; Kevin G F Thomas; John Joska Journal: J Neurovirol Date: 2022-09-01 Impact factor: 3.739
Authors: Rowan Saloner; Mariana Cherner; David J Grelotti; Emily W Paolillo; David J Moore; Robert K Heaton; Scott L Letendre; Adarsh Kumar; Igor Grant; Ronald J Ellis Journal: Brain Behav Immun Date: 2020-09-20 Impact factor: 7.217
Authors: Jordan N Kohn; Matthew Shane Loop; Julie J Kim-Chang; Patricia A Garvie; John W Sleasman; Bernard Fischer; H Jonathon Rendina; Steven Paul Woods; Sharon L Nichols; Suzi Hong Journal: J Acquir Immune Defic Syndr Date: 2021-06-01 Impact factor: 3.771
Authors: Rowan Saloner; Erin E Morgan; Mariam A Hussain; David J Moore; Robert K Heaton; Mariana Cherner; Igor Grant; Jennifer E Iudicello Journal: J Neurovirol Date: 2022-01-03 Impact factor: 3.739
Authors: Rowan Saloner; Emily W Paolillo; Robert K Heaton; David J Grelotti; Murray B Stein; Andrew H Miller; J Hampton Atkinson; Scott L Letendre; Ronald J Ellis; Igor Grant; Jennifer E Iudicello; David J Moore Journal: J Neurovirol Date: 2021-01-06 Impact factor: 3.739
Authors: Liana V Basova; Savannah Eve Lukkes; Richard Milner; Ronald J Ellis; Mariana Cherner; Jennifer Iudicello; Maria Cecilia Garibaldi Marcondes Journal: Brain Behav Immun Health Date: 2022-01-15
Authors: Margarita Bronshteyn; Fan Nils Yang; Kyle F Shattuck; Matthew Dawson; Princy Kumar; David J Moore; Ronald J Ellis; Xiong Jiang Journal: Hum Brain Mapp Date: 2021-06-05 Impact factor: 5.038
Authors: Pariya L Fazeli; John D Cheatwood; Cierra Hopkins; David E Vance; Maria R Shirey; Andres Azuero; Michael Crowe Journal: Appl Neuropsychol Adult Date: 2021-06-24 Impact factor: 2.050